NeuroOne Medical Technologies Corporation (Nasdaq: NMTC), a medical technology company focused on transforming surgical diagnosis and treatment of neurological disorders, announced today that it will participate in the Planet MicroCap Las Vegas 2026 Conference, scheduled for June 17-18, 2026. Dave Rosa, President and Chief Executive Officer, will attend the conference in Las Vegas, Nevada, where he is set to host one-on-one meetings with institutional investors and deliver a company presentation.
The presentation is scheduled for Wednesday, June 17, 2026, at 12:00 p.m. Pacific Time / 3:00 p.m. Eastern Time in TRACK 6 – Raphael 3. Rosa will provide commercialization updates and anticipated milestones for the OneRF® platform, which is designed for the treatment of the brain, pain, and advanced drug delivery. According to the press release, the OneRF® platform includes the OneRF® Ablation System for the brain and the OneRF® Trigeminal Nerve Ablation System, both of which have received FDA clearance.
The conference appearance comes as NeuroOne continues to advance its electrode technology platform, which includes four FDA-cleared product families: Evo® Cortical Electrodes, Evo® sEEG Electrodes, OneRF® Ablation System (for brain), and OneRF® Trigeminal Nerve Ablation System. These solutions aim to reduce hospitalizations and surgical procedures while improving patient outcomes by offering both diagnostic and therapeutic functions. The company is also engaged in research and development for drug delivery, basivertebral nerve ablation, and spinal cord stimulation programs.
In addition to the presentation, Rosa participated in a CEO interview with Planet MicroCap host Robert Kraft ahead of the conference. The interview is available for viewing online. For more information about the Planet MicroCap Las Vegas 2026 Conference or to schedule a meeting with management, interested parties can contact their conference representative or reach out via email to NMTC@mzgroup.us or by phone to Chris Tyson at (949) 491-8235.
NeuroOne’s participation in the conference underscores its commitment to engaging with the investment community and providing updates on its commercial progress. The company’s focus on minimally invasive, high-definition electrode technology positions it as a key player in the neurological device market. The updates on the OneRF® platform are particularly significant as the company seeks to expand its footprint in the treatment of neurological disorders.
For further details, the webcast of the presentation can be accessed here, and the conference website is available here. The CEO interview can be viewed here.
This news story relied on content distributed by NewMediaWire. Blockchain Registration, Verification & Enhancement provided by NewsRamp™. The source URL for this press release is NeuroOne to Present Commercialization Updates at Planet MicroCap Las Vegas Conference.